Skip Navigation



Rheumatology Advance Access published online on June 14, 2005
Rheumatology, doi:10.1093/rheumatology/keh714
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow CME/CE:
Take the course for this article:
 Rheumatology Third Quarter 2005 Quiz
Right arrow Supplementary Data
Right arrow All Versions of this Article:
44/11/1354    most recent
keh714v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ramos-Casals, M.
Right arrow Articles by Font, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramos-Casals, M.
Right arrow Articles by Font, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received March 30, 2005
Accepted May 17, 2005

Review

Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts

M. Ramos-Casals 1* and J. Font 1

1 Department of Autoimmune Diseases, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Hospital Clinic, Barcelona, Spain

* To whom correspondence should be addressed.
M. Ramos-Casals, E-mail: mramos{at}clinic.ub.es



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
P. N. Correia, G. H. Carpenter, K. L. Paterson, and G. B. Proctor
Inducible nitric oxide synthase increases secretion from inflamed salivary glands
Rheumatology, November 20, 2009; (2009) kep313v1.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Ramos-Casals, P. Brito-Zeron, N. Soria, N. Nardi, A. Vargas, S. Munoz, A. Bove, B. Suarez, and F. Lozano
Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjogren's syndrome
Rheumatology, January 1, 2009; 48(1): 65 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. Brito-Zeron, M. Ramos-Casals, A. Bove, J. Sentis, and J. Font
Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors
Rheumatology, August 1, 2007; 46(8): 1359 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
L. J. Dawson, P. C. Fox, and P. M. Smith
Sjogrens syndrome--the non-apoptotic model of glandular hypofunction
Rheumatology, July 1, 2006; 45(7): 792 - 798.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.